Responses to parliamentary questions
Question from Deputy Ken O’Flynn - PQ 32772-26
Deputy O'Flynn asked about the number of patients eligible for treatment with omaveloxolone for Friedreich’s ataxia. Read the HSE response.
From: Communications and public affairs
Published: May 2026
Updated: June 2026
Documents
Question from Deputy Ken O’Flynn - PQ 32772-26
PDF, 434KB, 1 pages
Summary
To ask the Minister for Health the number of patients in the State known to the HSE or the Department of Health who are clinically eligible for treatment with omaveloxolone, marketed as Skyclarys, for Friedreich’s ataxia; and if this number has informed any budget impact assessment.
This is a beta version - your feedback will help us to improve it